Tatjana Jatsenko
Overview
Explore the profile of Tatjana Jatsenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Passemiers A, Tuveri S, Jatsenko T, Vanderstichele A, Busschaert P, Coosemans A, et al.
Genome Biol
. 2025 Mar;
26(1):49.
PMID: 40055826
Cell-free DNA (cfDNA) is a rich source of biomarkers for various pathophysiological conditions. Preanalytical variables, such as the library preparation protocol or sequencing platform, are major confounders of cfDNA analysis....
2.
Paluoja P, Jatsenko T, Teder H, Krjutskov K, Vermeesch J, Salumets A, et al.
Prenat Diagn
. 2025 Feb;
45(3):352-361.
PMID: 39921343
Objective: Clinically pathogenic chromosomal microdeletions cause severe genetic disorders. Motivated by the absence of reliable screening of microdeletions during the first-trimester screening, we developed BinDel, a software tool to determine...
3.
Che H, Stanley K, Jatsenko T, Thienpont B, Vermeesch J
Extracell Vesicles Circ Nucl Acids
. 2024 Dec;
3(3):216-234.
PMID: 39697489
Noninvasive sampling of an individual's body fluids is an easy means to capture circulating cell-free DNA (cfDNA). These small fragments of DNA carry information on the contributing cell's genome, epigenome,...
4.
Akand M, Jatsenko T, Muilwijk T, Gevaert T, Joniau S, Van der Aa F
Front Oncol
. 2024 Nov;
14:1424293.
PMID: 39497708
Bladder cancer (BC) is the most common malignancy of the urinary tract. About 75% of all BC patients present with non-muscle-invasive BC (NMIBC), of which up to 70% will recur,...
5.
Passemiers A, Tuveri S, Sudhakaran D, Jatsenko T, Laga T, Punie K, et al.
Bioinformatics
. 2024 Aug;
40(9).
PMID: 39177091
Motivation: Circulating-cell free DNA (cfDNA) is widely explored as a noninvasive biomarker for cancer screening and diagnosis. The ability to decode the cells of origin in cfDNA would provide biological...
6.
Stanley K, Jatsenko T, Tuveri S, Sudhakaran D, Lannoo L, Van Calsteren K, et al.
Nat Commun
. 2024 Mar;
15(1):2220.
PMID: 38472221
Circulating cell-free DNA (cfDNA) fragments have characteristics that are specific to the cell types that release them. Current methods for cfDNA deconvolution typically use disease tailored marker selection in a...
7.
van Riel M, Zhao Y, Jatsenko T, Lannoo L, Timmerman D, Vermeesch J
Clin Chem
. 2023 Jul;
69(9):1089-1091.
PMID: 37522347
No abstract available.
8.
Tsuiko O, El Ayeb Y, Jatsenko T, Allemeersch J, Melotte C, Ding J, et al.
Hum Reprod
. 2023 Jan;
38(3):511-519.
PMID: 36625546
Study Question: Can long-read amplicon sequencing be beneficial for preclinical preimplantation genetic testing (PGT) workup in couples with a de novo pathogenic variant in one of the prospective parents? Summary...
9.
Che H, Jatsenko T, Lannoo L, Stanley K, Dehaspe L, Vancoillie L, et al.
NPJ Genom Med
. 2022 Sep;
7(1):55.
PMID: 36100603
The early detection of tissue and organ damage associated with autoimmune diseases (AID) has been identified as key to improve long-term survival, but non-invasive biomarkers are lacking. Elevated cell-free DNA...
10.
Che H, Jatsenko T, Lenaerts L, Dehaspe L, Vancoillie L, Brison N, et al.
Clin Chem
. 2022 Jun;
68(9):1164-1176.
PMID: 35769009
Background: Cell-free DNA (cfDNA) analysis holds great promise for non-invasive cancer screening, diagnosis, and monitoring. We hypothesized that mining the patterns of cfDNA shallow whole-genome sequencing datasets from patients with...